Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 2
2017 7
2018 1
2019 4
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.
Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Müller S, Link H, Niederle N, Rost A, Höffkes HG, Moehler M, Lindig RU, Modest DP, Rossius L, Kirchner T, Jung A, Stintzing S. Heinemann V, et al. Among authors: hielscher j. Lancet Oncol. 2014 Sep;15(10):1065-75. doi: 10.1016/S1470-2045(14)70330-4. Epub 2014 Jul 31. Lancet Oncol. 2014. PMID: 25088940 Clinical Trial.
Mineral oil hydrocarbons in foods: is the data reliable?
Koster S, Varela J, Stadler RH, Moulin J, Cruz-Hernandez C, Hielscher J, Lesueur C, Roïz J, Simian H. Koster S, et al. Among authors: hielscher j. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020 Jan;37(1):69-83. doi: 10.1080/19440049.2019.1678770. Epub 2019 Oct 22. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2020. PMID: 31639315
Knee-ankle-foot orthosis with powered knee for support in the elderly.
Pott PP, Wolf SI, Block J, van Drongelen S, Grün M, Heitzmann DW, Hielscher J, Horn A, Müller R, Rettig O, Konigorski U, Werthschützky R, Schlaak HF, Meiß T. Pott PP, et al. Among authors: hielscher j. Proc Inst Mech Eng H. 2017 Aug;231(8):715-727. doi: 10.1177/0954411917704008. Epub 2017 May 3. Proc Inst Mech Eng H. 2017. PMID: 28466759
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial).
Michl M, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmueller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Mueller S, Lerch MM, Modest DP, Kirchner T, Jung A, Heinemann V; FIRE-3 Study Group. Michl M, et al. Among authors: hielscher j. Ann Oncol. 2016 Aug;27(8):1565-72. doi: 10.1093/annonc/mdw222. Epub 2016 May 27. Ann Oncol. 2016. PMID: 27234640 Free article. Clinical Trial.
14 results